Volume | 411 310 |
|
|||||
Actualités | - | ||||||
Maximum Haut | 4,175 | Bas Haut |
|||||
Minimum Bas | 4,00 |
Nom Action | Symbole Action | Marché | Type |
---|---|---|---|
ADC Therapeutics SA | ADCT | NYSE | Action ordinaire |
Ouverture | Plus Bas | Plus Haut | Prix de clôture | Clôture Veille |
---|---|---|---|---|
4,09 | 4,00 | 4,175 | 4,10 | 4,09 |
Transactions Totales | Volume échangé | VWAP | Volume Financier | Volume en moyenne | Sur 52 semaines |
---|---|---|---|---|---|
4 438 | 411 310 | US$ 4,08 | US$ 1 678 432 | - | 0,359908 - 6,04 |
Dernière Transaction | Type | Quantités échangées | Prix transaction | Devise |
---|---|---|---|---|
01:00:00 | 16 938 | US$ 4,10 | USD |
Bilan Comptable
Capitalisation Boursière | Actions en Circulation | Float | Chiffre d'affaires | Bénéfice/Perte | BPA | Ratio Cours sur Bénéfices |
---|---|---|---|---|---|---|
339,2M | 82,53M | - | 69,56M | -234,53M | -2,84 | - |
Short Interest | Dividendes Par Action | Rendement du Dividende | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
plus d’informations financières »
Actualités Action ADC Therapeutics
Date | Heure | Source | Titre |
---|---|---|---|
15/5/2024 | 13:15 | GlobeNewswire Inc. | ADC Therapeutics to Participate in the H.C. Wainwright 2nd.. |
14/5/2024 | 18:32 | Edgar (US Regulatory) | Form 8-K - Current report |
09/5/2024 | 22:06 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
09/5/2024 | 13:15 | GlobeNewswire Inc. | ADC Therapeutics to Participate in 2024 RBC Capital Markets.. |
08/5/2024 | 22:07 | Edgar (US Regulatory) | Form 8-K - Current report |
07/5/2024 | 22:06 | Edgar (US Regulatory) | Form 144 - Report of proposed sale of securities |
07/5/2024 | 22:02 | Edgar (US Regulatory) | Form 424B5 - Prospectus [Rule 424(b)(5)] |
06/5/2024 | 13:30 | GlobeNewswire Inc. | ADC Therapeutics Announces $105 Million Underwritten.. |
06/5/2024 | 12:51 | Edgar (US Regulatory) | Form 424B5 - Prospectus [Rule 424(b)(5)] |
06/5/2024 | 12:38 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
06/5/2024 | 12:29 | Edgar (US Regulatory) | Form 8-K - Current report |
06/5/2024 | 12:10 | GlobeNewswire Inc. | ADC Therapeutics Reports First Quarter 2024 Financial.. |
Forum Action ADC Therapeutics
Aucune Discussion TrouvéeAjouter une Discussion
Historiques ADC Therapeutics SA
Période | Ouver. | Haut | Bas | VWAP | Moyenne Vol. Quot. | Variation | % |
---|---|---|---|---|---|---|---|
1 semaine | 4,56 | 4,60 | 3,80 | 4,17 | 600 224 | -0,46 | -10,09% |
1 mois | 4,76 | 5,17 | 3,80 | 4,48 | 583 481 | -0,66 | -13,87% |
3 mois | 5,00 | 5,38 | 3,23 | 4,56 | 567 889 | -0,90 | -18,00% |
6 mois | 0,64 | 6,04 | 0,64 | 3,26 | 742 662 | 3,46 | 540,63% |
1 an | 2,50 | 6,04 | 0,359908 | 2,62 | 561 945 | 1,60 | 64,00% |
3 ans | 21,24 | 32,00 | 0,359908 | 6,24 | 428 987 | -17,14 | -80,70% |
5 ans | 30,00 | 56,5899 | 0,359908 | 10,73 | 387 554 | -25,90 | -86,33% |